Mr. John Hodgson

Director, Critical I. « How healthy is Europe's biotech ? What are the main headlines from the Critical I study published today ? ». « How does chronic under-funding affect economic competitiveness of European life sciences ? »

Dr. Andrea Rappagliosi

Vice President, Health Policy & Governmental Relations, Serono. Europabio Executive Committee Member. « If you needed to identify the root cause / the one single issue that should occupy the Commission for healthcare, what would that be ? So how do we address this issue ? »

Dr. Bernward Garthoff

President of the German BioIndustries Association (DIB). Chair of EuropaBio's Agri-food Council. « Is the Agri-Food sector making progress and what are you expecting from EU policy makers ? »

Mr. John HOLLOWAY

Director Investments, European Investment Fund (EIF). « How can private investors with government support produce biotechnology winners ? »

Dr. Johan VANHEMELRIJCK

Secretary General, EuropaBio. « There is a lot of new policies being advocated by EuropaBio Council's. What is EuropaBio doing with all these policies ? ». « We heard from Professor Debackhere about the proliferation of life science and biotechnology patents crossing into many other fields of activity for example bio-nano, bioinformatics, what does this mean for policy makers and regulators - are we equipped to deal with this convergence ? »

Mr. Iain GILLESPIE

Head of the Biotechnology Division, OECD. « Can bioscience underpin economic strategies ? »

Prof. Dr. Marc VAN MONTAGU

Chairman International Plant Biotechnology Organisation (IPBO) Gent University and President of the European Federation of Biotechnology. Marc Van Montagu is the inventor of the technology to create genetically modified (GM) plants and produced the first GM plant in Europe.. « What Europe should do to catch up with its worldwide competitors in agbiotech ? »

Dr. Hans KAST

President & CEO, BASF Plant. Science and Chairman of EuropaBio. « What has the biotech industry achieved, where is it heading and what can we expect over the next decade ? »

Mr. Michael GRIFFITH

Chair of the European Platform for Patients Organisations, Science and Industry (EPPOSI). « Can the model for rare diseases be exported to make changes in the way healthcare systems and drug developments work ? »

Lord Dick TAVERNE

House of Lords (UK). « Why must the EU not reject genetic modification ? »

Ms. Aisling BURNAND

Chief Executive Officer, BioIndustry Association, UK. Chair of EuropaBio's National Associations Council. « The UK is leading the biotech sector in Europe, how does this measure up against other nations ? The benchmark for Europe is the US, where we see a major gap, what is Europe doing wrong ? »

Dr. Philippe ARCHINARD

Chief Executive Officer, Transgene. Newly elected Chair of EuropaBio's Emerging Enterprise Councils. « Today's figures showed that biotech is chronically under-funded, how is the Emerging Enterprises Council going to tackle this ? »

Mr. Pierre ERWES

Chief Executive Officer, Biovision. « Announcing Biovision 2007 »

Dr. Hans KAST

President & CEO, BASF Plant Science and Chairman of EuropaBio. « What kind of priorities have the members given to EuropaBio for the next year ? »

Mr. Robert GOEBBELS

Member of the European Parliament. « Is the European Parliament ready to support the industrial development of biotechnologies in Europe ? »

EuropaBio's Open Day

Welcome & Keynote Speech - Welcome

Mr. Martin Neumeyer, Director General of the State Minister for Federal and European Affairs in the Bavarian State Chancellery

EuropaBio's Open Day

Welcome & Keynote Speech - Introduction

Dr Hans Kast, EuropaBio Chairman, President & CEO of BASF Plant Science

EuropaBio's Open Day

Welcome & Keynote Speech

Mr. Peter Mandelson, European Commissioner for External Trade

EuropaBio's Open Day

Towards a patient centred healthcare system

- Dr. Andrea Rappagliosi, EuropaBio Healthcare Council Chair, Merck Serono
- Mr. Thomas Bols, Director government affairs Amgen
- Mr. Simon Rozendaal, author of 'It's MY Life'
- Panel discussion with patient representatives, Mr. Ysbrand Poortman & Ms. Beatrice De Schepper

EuropaBio's Open Day

From Lisbon to the knowledge based bio-economy

Mr. Nicolas Denis, Associate Principal McKinsey

EuropaBio's Open Day

From Lisbon to the knowledge based bio-economy

- Mr. Nicolas Denis, Associate Principal McKinsey
- Mr. Jack Huttner, EuropaBio Industrial Biotech Council Chair, Genencor - a Danisco Division
- Dr. Bernward Garthoff, EuropaBio Agri-Food Council Chair, Bayer CropScience, DIB
- Dr. George Tzotzos, Chief Biotechnology Unit UNIDO
- Mr. Julien Mousnier, Mid-Term Review Policy Coordinator European Commission
- Panel discussion

EuropaBio's Open Day

Closing Remarks

EuropaBio Secretary General Dr. Johan Vanhemelrijck

EuropaBio's Open Day

Welcome & Keynote Speech

Mr. Patrick Wall, Chairman EFSA Management Board

EuropaBio's Open Day

Introduction

Moderator Mr. Peter O'Donnell, editor Talk About Europe

EuropaBio's Open Day

Style Debate

The UK House of Commons format

Mr. Etienne VERVAECKE, General Commissioner Eurobio 2007 and 2009

EuroBio 2007 edition : A clear acceleration in the development of the event

Mr. Etienne VERVAECKE, CEO Gie EURASANTE

Huge investment in the biotech and nutrition sector in Lille confirms this cluster's attractiveness

Ms. Martine LEMAIRE, Senior Director Scientific & Business Development - PORSOLT & PARTNERS PHARMACOLOGY

Announcement : Services in animal pharmacology for almost 20 years

Mr. Philippe FORNIES, CEO GENAXION

Announcement: Genaxion is a global sales organization focused on biotech, pharmaceuticals, cosmetic, diagnostics and chemical market

Mr. Stuart Mc Keen, Ministry of research and Innovation, Ontario

Ontario's looking for collaboration for companies with France and Europe

Mr. François Lescure, Chairman MidiBiotech & Montserrat VENDRELL, CEO BioRegion of Catalonia

Save the date : December 3rd and 4th Location: Toulouse For the first Euro Region Biotech and Healthcare Meeting held by MIdiBIotech and the Region of Catalunya

Mr. Pierre Nokin, Managing Director Biowin

Health Cluster of Wallonia short presentation

Johan Vanhemelrijck, Europabio

Presents the EuropaBio strategy for the coming months

« If you want to be part of the discussion with the EMEA, join EuropaBio! »